Total body irradiation in Australia and New Zealand: results of a practice survey.


Journal

Physical and engineering sciences in medicine
ISSN: 2662-4737
Titre abrégé: Phys Eng Sci Med
Pays: Switzerland
ID NLM: 101760671

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 23 01 2020
accepted: 04 05 2020
pubmed: 3 7 2020
medline: 7 7 2021
entrez: 3 7 2020
Statut: ppublish

Résumé

Total body irradiation (TBI) is an important treatment modality for the preparation of patients for bone marrow transplants. It is technically challenging and the actual delivery may vary from clinic to clinic. Knowledge of the pattern of practice may be helpful for clinics to determine future practice. We carried out an email survey from April to September 2019 sending 48 TBI related questions to all radiotherapy clinics in Australia and New Zealand via the Australasian College of Physical Scientists in Medicine email distribution list. Centres not performing TBI were not expected to complete the survey and centres that had participated in a previous survey, or that were known to perform the treatment, were followed up if no response was received. Of a total of approximately 70 centres, 14 clinics responded to the survey. The vast majority of clinics use conventional lateral and/or anterior-posterior beams at extended SSD for TBI treatment delivery. However, treatment planning, ancillary equipment (used for immobilisation/modulation), beam energy and prescribed lung doses vary considerably-with some clinics delivering the prescription dose to the lungs and some aiming to deliver a lung dose which is lower than the prescription dose. Only one clinic reported using an advanced delivery technique with modulated arcs at extended SSD. Centres either said they had no access to outcome data or did not answer this question. Compared with an earlier survey from 2005, 3 clinics have lowered their linac dose rate and 7 are the same or similar. The TBI practice in Australia and New Zealand remains varied, with considerable differences in treatment planning, beam energy, accepted lung doses and delivered dose rates.

Identifiants

pubmed: 32613526
doi: 10.1007/s13246-020-00878-z
pii: 10.1007/s13246-020-00878-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-835

Auteurs

Lotte S Fog (LS)

Alfred Health Radiation Oncology, The Alfred Hospital, 55 Commercial Rd, Melbourne, VIC, 3004, Australia. lottesfog@yahoo.co.uk.

Andrew Wirth (A)

The Peter MacCallum Cancer Centre, Grattan St, Melbourne, 3000, Australia.

Michael MacManus (M)

The Peter MacCallum Cancer Centre, Grattan St, Melbourne, 3000, Australia.

Simon Downes (S)

Prince of Wales Hospital, 320-346 Barker St, Randwick, NSW, 2031, Australia.

Michael Grace (M)

Genesis Care, Level A, St. Vincents Hospital, 438 Victoria St, Darlinghurst, NSW, 2010, Australia.

Alicia Moggré (A)

Christchurch Hospital, 2 Riccarton Ave, Christchurch Central, Christchurch, 8011, New Zealand.

Koki Mugabe (K)

Waikato Hospital, Pembroke Street, Hamilton West, Hamilton, 3204, New Zealand.

Gabor Neveri (G)

Sir Charles Gairdner Hospital, Hospital Ave, Nedlands, WA, 6009, Australia.

Lisa Nourbehesht (L)

Crown Princess Mary Cancer Centre Westmead, Cnr Hawkesbury Road and Darcy Rd, Westmead, NSW, 2145, Australia.

Vanessa Panettieri (V)

Alfred Health Radiation Oncology, The Alfred Hospital, 55 Commercial Rd, Melbourne, VIC, 3004, Australia.

Dane Pope (D)

Chris O'Brien Lifehouse, 119-143 Missenden Rd, Camperdown, NSW, 2050, Australia.

Lucy Sim (L)

Radiation Oncology Princess, Alexandra Raymond Terrace - 31 Raymond Terrace, South Brisbane, QLD, 4101, Australia.

Cameron Stanton (C)

Northern Sydney Cancer Centre, Reserve Rd, St Leonards, NSW, 2065, Australia.

Blair Steer (B)

Wellington Regional Hospital, Riddiford Street, Newtown, Wellington, 6021, New Zealand.

Allan Stewart (A)

Auckland City Hospital, 2 Park Rd, Grafton, Auckland, 1023, New Zealand.

Elena Ungureanu (E)

The Peter MacCallum Cancer Centre, Grattan St, Melbourne, 3000, Australia.

Tomas Kron (T)

The Peter MacCallum Cancer Centre, Grattan St, Melbourne, 3000, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH